SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00029



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00029_20170831_QEh1_LC1_ChC_SA_HLAIp_ONVC_DAC 8 Human HLA-A03_01,HLA-A26_01,HLA-B38_01,HLA-B40_01,HLA-C03_04,HLA-C12_03
SYSMHC00029_20170901_QEh1_LC1_ChC_SA_HLAIp_ONVC_ctrl 8 Human HLA-A03_01,HLA-A26_01,HLA-B38_01,HLA-B40_01,HLA-C03_04,HLA-C12_03
SYSMHC00029_20170903_QEh1_LC1_ChC_SA_HLAIp_OMM475_DAC 4 Human HLA-A01_01,HLA-A30_02,HLA-B08_01,HLA-B18_01,HLA-C05_01,HLA-C07_01
SYSMHC00029_20170903_QEh1_LC1_ChC_SA_HLAIp_OMM475_ctrl 3 Human HLA-A01_01,HLA-A30_02,HLA-B08_01,HLA-B18_01,HLA-C05_01,HLA-C07_01
SYSMHC00029_20170913_QEh1_LC1_CHC_SA_HLAIp_OD5P_DAC 8 Human HLA-A01_01,HLA-A23_01,HLA-B07_02,HLA-B15_01,HLA-C12_03,HLA-C14_02
SYSMHC00029_20170913_QEh1_LC1_CHC_SA_HLAIp_OD5P_ctrl 8 Human HLA-A01_01,HLA-A23_01,HLA-B07_02,HLA-B15_01,HLA-C12_03,HLA-C14_02
SYSMHC00029_20180222_QE_HFX_LC2_HLAIIp_JMI_SA_Me290 2 Human no allele
SYSMHC00029_20180222_QE_HFX_LC2_HLAIp_JMI_SA_Me275 2 Human HLA-A02_01,HLA-A23_01,HLA-B07_02,HLA-C07_02
SYSMHC00029_20180222_QE_HFX_LC2_HLAIp_JMI_SA_Me290 2 Human HLA-A01_01,HLA-A02_01,HLA-B07_02,HLA-B08_01,HLA-C07_01,HLA-C07_02
SYSMHC00029_20180309_QE_HFX_LC2_HLAIIp_CHC_SA_tumC3N02289 3 Human no allele
SYSMHC00029_20180309_QE_HFX_LC2_HLAIp_CHC_SA_tumC3N02289 3 Human HLA-A03_01,HLA-A26_01,HLA-B15_22,HLA-B18_01,HLA-C07_01,HLA-C12_03
SYSMHC00029_20180424_QE_HFX_LC2_HLAIIp_CHC_SA_normC3N02289 2 Human no allele
SYSMHC00029_20180424_QE_HFX_LC2_HLAIp_CHC_SA_normC3N02289 1 Human HLA-A03_01,HLA-A26_01,HLA-B15_22,HLA-B18_01,HLA-C07_01,HLA-C12_03
SYSMHC00029_20180425_QE_HFX_LC2_HLAIIp_CHC_SA_normC3N02671 3 Human no allele
SYSMHC00029_20180425_QE_HFX_LC2_HLAIp_CHC_SA_normC3N02671 3 Human HLA-A01_01,HLA-A02_01,HLA-B08_01,HLA-B44_02,HLA-C05_01,HLA-C07_01
SYSMHC00029_20180426_QE_HFX_LC2_HLAIIp_CHC_SA_tumC3N02671 3 Human no allele
SYSMHC00029_20180426_QE_HFX_LC2_HLAIp_CHC_SA_tumC3N02671 3 Human HLA-A01_01,HLA-A02_01,HLA-B08_01,HLA-B44_02,HLA-C05_01,HLA-C07_01
SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1015A 4 Human HLA-A02_09,HLA-A32_01,HLA-B35_03,HLA-B49_01,HLA-C04_01,HLA-C07_01
SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B 11 Human HLA-A02_01,HLA-A68_01,HLA-B13_02,HLA-B40_01,HLA-C03_04,HLA-C06_02
SYSMHC00029_20180725_QEh1_LC1_SA_JMI_HLAIIp_T1015A 4 Human no allele



Detailed view of sample SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00029 SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B 20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B_IFN3_R01.raw Human In vivo Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A68_01,HLA-B13_02,HLA-B40_01,HLA-C03_04,HLA-C06_02 32157095 native Immunoaffinity W6/32 Q-Exactive Easy-nLC 1200 no DDA HCD 1
SYSMHC00029 SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B 20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B_IFN2_R02.raw Human In vivo Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A68_01,HLA-B13_02,HLA-B40_01,HLA-C03_04,HLA-C06_02 32157095 native Immunoaffinity W6/32 Q-Exactive Easy-nLC 1200 no DDA HCD 2
SYSMHC00029 SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B 20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B_IFN2_R01.raw Human In vivo Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A68_01,HLA-B13_02,HLA-B40_01,HLA-C03_04,HLA-C06_02 32157095 native Immunoaffinity W6/32 Q-Exactive Easy-nLC 1200 no DDA HCD 3
SYSMHC00029 SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B 20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B_IFN1_R02.raw Human In vivo Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A68_01,HLA-B13_02,HLA-B40_01,HLA-C03_04,HLA-C06_02 32157095 native Immunoaffinity W6/32 Q-Exactive Easy-nLC 1200 no DDA HCD 4
SYSMHC00029 SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B 20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B_IFN1_R01.raw Human In vivo Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A68_01,HLA-B13_02,HLA-B40_01,HLA-C03_04,HLA-C06_02 32157095 native Immunoaffinity W6/32 Q-Exactive Easy-nLC 1200 no DDA HCD 5
SYSMHC00029 SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B 20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B_C3_R01.raw Human In vivo Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A68_01,HLA-B13_02,HLA-B40_01,HLA-C03_04,HLA-C06_02 32157095 native Immunoaffinity W6/32 Q-Exactive Easy-nLC 1200 no DDA HCD 6
SYSMHC00029 SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B 20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B_IFN3_R02.raw Human In vivo Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A68_01,HLA-B13_02,HLA-B40_01,HLA-C03_04,HLA-C06_02 32157095 native Immunoaffinity W6/32 Q-Exactive Easy-nLC 1200 no DDA HCD 7
SYSMHC00029 SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B 20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B_C2_R01.raw Human In vivo Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A68_01,HLA-B13_02,HLA-B40_01,HLA-C03_04,HLA-C06_02 32157095 native Immunoaffinity W6/32 Q-Exactive Easy-nLC 1200 no DDA HCD 8
SYSMHC00029 SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B 20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B_C1_R02.raw Human In vivo Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A68_01,HLA-B13_02,HLA-B40_01,HLA-C03_04,HLA-C06_02 32157095 native Immunoaffinity W6/32 Q-Exactive Easy-nLC 1200 no DDA HCD 9
SYSMHC00029 SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B 20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B_C1_R01.raw Human In vivo Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A68_01,HLA-B13_02,HLA-B40_01,HLA-C03_04,HLA-C06_02 32157095 native Immunoaffinity W6/32 Q-Exactive Easy-nLC 1200 no DDA HCD 10
SYSMHC00029 SYSMHC00029_20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B 20180721_QEh1_LC1_SA_JMI_HLAIp_T1185B_C3_R02.raw Human In vivo Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A68_01,HLA-B13_02,HLA-B40_01,HLA-C03_04,HLA-C06_02 32157095 native Immunoaffinity W6/32 Q-Exactive Easy-nLC 1200 no DDA HCD 11